CIK: 0001855655 · Show all filings
Period: Q2 2024 (← Previous) (Next →)
Filing Date: Aug 14, 2024
Total Value ($000): $2,613,016 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| NUVL | NUVALENT INC | 4,571,678 | $346,807 | 13.3% | $56.04 | +26.9% | COM | 670703107 |
| ARGX | ARGENX SE | 538,139 | $231,421 | 8.9% | $406.28 | — | SPONSORED ADR | 04016X101 |
| ACLX | ARCELLX INC | 3,848,095 | $212,376 | 8.1% | $34.61 | +57.0% | COMMON STOCK | 03940C100 |
| RVMD | REVOLUTION MEDICINES INC | 5,259,089 | $204,105 | 7.8% | $33.09 | +13.0% | COM | 76155X100 |
| SRPT | SAREPTA THERAPEUTICS INC | 947,574 | $149,717 | 5.7% | $122.50 | +4.9% | COM | 803607100 |
| IRON | DISC MEDICINE INC | 2,704,718 | $121,902 | 4.7% | $48.64 | -30.1% | COM | 254604101 |
| — | MERUS N V | 2,019,814 | $119,512 | 4.6% | $59.17 | — | COM | N5749R100 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 2,513,302 | $112,571 | 4.3% | $25.24 | +83.0% | COM | 22663K107 |
| — | CEREVEL THERAPEUTICS HLDNG I | 2,330,508 | $95,294 | 3.6% | $24.52 | — | COM | 15678U128 |
| KURA | KURA ONCOLOGY INC | 4,539,381 | $93,466 | 3.6% | $17.57 | +17.0% | COM | 50127T109 |
| ASND | ASCENDIS PHARMA A/S | 664,307 | $90,598 | 3.5% | $134.34 | — | SPONSORED ADR | 04351P101 |
| OLMA | OLEMA PHARMACEUTICALS INC | 7,903,600 | $85,517 | 3.3% | $7.68 | +41.2% | COM | 68062P106 |
| XENE | XENON PHARMACEUTICALS INC | 2,043,280 | $79,667 | 3.0% | $38.31 | +4.3% | COM | 98420N105 |
| TARS | TARSUS PHARMACEUTICALS INC | 2,435,416 | $66,195 | 2.5% | $24.85 | +35.3% | COM | 87650L103 |
| JANX | JANUX THERAPEUTICS INC | 1,564,452 | $65,535 | 2.5% | $46.95 | 0.0% | COM | 47103J105 |
| ARVN | ARVINAS INC | 2,438,149 | $64,904 | 2.5% | $36.46 | -12.6% | COM | 04335A105 |
| LEGN | LEGEND BIOTECH CORP | 1,203,308 | $53,295 | 2.0% | $50.82 | — | SPONSORED ADS | 52490G102 |
| PCVX | VAXCYTE INC | 627,202 | $47,360 | 1.8% | $69.25 | -1.7% | COM | 92243G108 |
| — | Y-MABS THERAPEUTICS INC | 3,870,594 | $46,757 | 1.8% | $14.49 | — | COM | 984241109 |
| EWTX | EDGEWISE THERAPEUTICS INC | 2,325,449 | $41,881 | 1.6% | $15.89 | +9.7% | COM | 28036F105 |
| IMTX | IMMATICS N.V | 3,421,965 | $39,763 | 1.5% | $10.19 | +10.6% | SHS | N44445109 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 2,896,349 | $37,682 | 1.4% | $19.51 | -29.1% | COM | 92790C104 |
| IMVT | IMMUNOVANT INC | 1,362,827 | $35,979 | 1.4% | $33.16 | -14.2% | COM | 45258J102 |
| COGT | COGENT BIOSCIENCES INC | 3,624,342 | $30,553 | 1.2% | $7.58 | 0.0% | COM | 19240Q201 |
| BBIO | BRIDGEBIO PHARMA INC | 1,089,492 | $27,597 | 1.1% | $27.34 | 0.0% | COM | 10806X102 |
| CGEM | CULLINAN THERAPEUTICS INC | 1,542,805 | $26,907 | 1.0% | $16.19 | +31.5% | COM | 230031106 |
| ERAS | ERASCA INC | 7,250,000 | $17,110 | 0.7% | $2.16 | 0.0% | COM | 29479A108 |
| CMPS | COMPASS PATHWAYS PLC | 2,335,926 | $14,109 | 0.5% | $7.96 | — | SPONSORED ADS | 20451W101 |
| APGE | APOGEE THERAPEUTICS INC | 330,000 | $12,986 | 0.5% | $43.66 | +11.2% | COM | 03770N101 |
| — | VERONA PHARMA PLC | 721,087 | $10,427 | 0.4% | $14.46 | — | SPONSORED ADS | 925050106 |
| ALXO | ALX ONCOLOGY HLDGS INC | 1,575,605 | $9,501 | 0.4% | $12.30 | 0.0% | COM | 00166B105 |
| CATX | PERSPECTIVE THERAPEUTICS INC | 919,692 | $9,169 | 0.4% | $14.46 | 0.0% | COM NEW | 46489V302 |
| — | VOR BIOPHARMA INC | 6,457,293 | $6,457 | 0.2% | $6.84 | — | COM | 929033108 |
| ACRV | ACRIVON THERAPEUTICS INC | 659,724 | $3,826 | 0.1% | $8.05 | 0.0% | COMMON STOCK | 004890109 |
| TCRX | TSCAN THERAPEUTICS INC | 353,886 | $2,070 | 0.1% | $7.88 | 0.0% | COM | 89854M101 |